Scpharmaceuticals Inc (SCPH) Inventory Turnover Ratio, from second quarter 2025 to second quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Scpharmaceuticals Inc   (NASDAQ: SCPH)
 

Scpharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Scpharmaceuticals Inc inventory turnover ratio, the Scpharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2025, sequentially increased to 1.04 in the second quarter 2025, a new company high. Average inventory processing period, for the Scpharmaceuticals Inc in Jun 30 2025 quarter, has decreased to 351 days, compare to 429 days, in the Mar 31 2025 quarter.

Within Healthcare sector 318 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2025, to 972, from total ranking in the first quarter 2025 at 1614.

SCPH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Scpharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCPH Inventory Turnover Ratio (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Inventory Growth -4.8 % 47.73 % 57.27 % 154.2 % 162.48 %
Y / Y Cost of Sales Growth 117.87 % 94.45 % 123.63 % 206.86 % 549.72 %
Inventory Turnover Ratio (TTM) 1.04 0.85 0.8 0.71 0.68
SCPH's Total Ranking # 972 # 1614 # 1849 # 1849 # 1822
Average inventory processing period 352 430 457 516 537
Seq. Inventory Growth 3.05 % 1.71 % -23.22 % 18.28 % 59.92 %
Seq. Cost of Sales Growth 44.37 % -12.46 % 19.75 % 43.96 % 28.85 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 94
Healthcare Sector # 319
Overall Market # 972

Inventory Turnover Ratio Statistics
High Average Low
1.04 0.72 0.46
(Jun 30 2025)   (Sep 30 2023)



SCPH Company Profile >> Back to SCPH Efficiency Comparisons >> Compare SCPH Inventory Turnover Ratio to its Competitors

Financial Statements
Scpharmaceuticals Inc 's Inventories $ 15 Millions Visit SCPH's Balance sheet
Scpharmaceuticals Inc 's Cost of Revenues TTM $ 16 Millions Visit SCPH's Income Statement
What are SCPH's Sales? Visit SCPH's Sales by Segment

Other Inventory Turnover Ratios
Scpharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SCPH's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SCPH's Competitors
Inventory Turnover Ratio for SCPH's Suppliers
Inventory Turnover Ratio for SCPH's Customers

You may also want to know
SCPH's Sales Growth Rates SCPH's Pe Price to earnings ratio SCPH's Receivables Turnover Ratio SCPH's Stock Quote
SCPH's Net Income Growth Rates SCPH's Ps Price to Sales ratio SCPH's Sales per Employee SCPH's Asset Turnover Ratio
SCPH's Net Margin SCPH's Pb Price to Book ratio SCPH's Financial Strength Ratios SCPH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2025 Inventories at quarter ending Jun 30 2025
Amneal Pharmaceuticals Inc   2.94 $ 1,776.645  Millions$ 605  Millions
Urogen Pharma Ltd   2.92 $ 10.804  Millions$ 4  Millions
International Stem Cell Corporation  2.91 $ 3.883  Millions$ 1  Millions
Iridex Corp  2.88 $ 29.000  Millions$ 10  Millions
Dentsply Sirona Inc   2.87 $ 1,774.000  Millions$ 618  Millions
Elite Pharmaceuticals Inc   2.87 $ 45.000  Millions$ 16  Millions
Bausch Health Companies Inc   2.87 $ 2,824.000  Millions$ 986  Millions
Organogenesis Holdings Inc   2.85 $ 82.443  Millions$ 29  Millions
Abbott Laboratories  2.85 $ 18,962.000  Millions$ 6,650  Millions
Akebia Therapeutics Inc   2.85 $ 52.069  Millions$ 18  Millions
Mimedx Group Inc   2.80 $ 68.000  Millions$ 24  Millions
Nexgel Inc   2.79 $ 5.011  Millions$ 2  Millions
Revvity Inc  2.74 $ 1,057.641  Millions$ 385  Millions
Axsome Therapeutics Inc   2.72 $ 44.093  Millions$ 16  Millions
Orthofix Medical Inc   2.67 $ 266.226  Millions$ 100  Millions
Lftd Partners Inc   2.63 $ 25.340  Millions$ 10  Millions
Caredx Inc   2.60 $ 58.190  Millions$ 22  Millions
Biomerica Inc   2.58 $ 4.813  Millions$ 2  Millions
Livanova Plc  2.58 $ 405.536  Millions$ 157  Millions
Zynex inc   2.57 $ 35.584  Millions$ 14  Millions
Illumina Inc   2.57 $ 1,433.000  Millions$ 558  Millions
Quidelortho Corp  2.57 $ 1,445.000  Millions$ 563  Millions
Tenon Medical Inc   2.56 $ 1.608  Millions$ 1  Millions
Intelligent Bio Solutions Inc   2.55 $ 1.806  Millions$ 1  Millions
Bioxcel Therapeutics Inc   2.53 $ 2.122  Millions$ 1  Millions
Cytosorbents Corporation  2.52 $ 8.000  Millions$ 3  Millions
China Pharma Holdings Inc  2.52 $ 5.300  Millions$ 2  Millions
Phibro Animal Health Corporation  2.50 $ 896.273  Millions$ 358  Millions
Immucell Corporation  2.50 $ 18.892  Millions$ 8  Millions
Icu Medical Inc  2.45 $ 1,521.264  Millions$ 621  Millions

Date modified: 2026-08-29T17:39:09+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.